47-target safety panel screening

Product Details

√ Target List was recommended by AZ, GSK, Novartis and Pfizer in 2012

√ ICE’s Functional assay correlated better to the physiological and pharmacological function

√ Both agonist and antagonist modes are available

√ Flexible in target selection and assay formats:

o FLIPR/cAMP/IP1/Reporter gene assay

o Biochemical assay/Electrophysiological assay

o GPCR x 24

o Ion channel x 8

o Enzyme x 10/

o Monoamine transporter x 3

o Nuclear receptor x 2

√ Fast turnaround time, 3-4 weeks

√ Cost effective

√ Include reference compound in each run

√ 100+ target panel is under validation

√ Currently we have 70 targets are ready

√ Provide both CN and EN version reports

√ Enable IND filing